Ross J. Baldessarini Explained

Ross J. Baldessarini (born 1937, Western Massachusetts),^[1] a psychopharmacologist, is the Director, International Consortium for Bipolar & Psychotic Disorders Research at McLean Hospital and Professor of Psychiatry (Neuroscience) at Harvard Medical School.^[2]

Education

• 1959 AB in Chemistry, Williams College
• 1963 MD, Johns Hopkins University School of Medicine

Publications

Books

Chemotherapy in Psychiatry: Pharmacologic Basis of Treatments for Major Mental Illness

Selected journal articles

• Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment of bipolar depression. International Journal of Neuropsychopharmacology 2013;16(7):1673-1685.
• Yildiz A, Vieta E, Nikodem M, Correll CU, Baldessarini RJ. A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine 2014;1–19.
• Schalkwijk S, Undurraga J, Tondo L, Baldessarini RJ. Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. International Journal of Neuropsychopharmacology 2014;17(8):1343-1352.

External links

• Ross J. Baldessarini, D.Sc., M.D. at Harvard Catalyst

Notes and References

1. Web site: Ross J. Baldessarini, M.D., M.A. (hon.), D.Sc. (hon.), DLFAPA, FACP, FACNP, FCINP . International Network for the History of Neuropsychopharmacology . 25 June 2021.
2. Web site: Ross J. Baldessarini, MD . McLean Hospital . 25 June 2021.